Cargando…
Inclusion of Metabolic Tumor Volume in Prognostic Models of Bone and Soft Tissue Sarcoma Increases the Prognostic Value
SIMPLE SUMMARY: Sarcoma is a rare cancer originating in soft tissue or bone. Prognostic models are used to modify therapy and improve survival. The present study aimed to evaluate if the combination of PET parameters and circulating biomarkers can improve the prognostic accuracy. When PET parameters...
Autores principales: | Pedersen, Mette Abildgaard, Baad-Hansen, Thomas, Gormsen, Lars C., Bærentzen, Steen, Sandfeld-Paulsen, Birgitte, Aggerholm-Pedersen, Ninna, Vendelbo, Mikkel Holm |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9913525/ https://www.ncbi.nlm.nih.gov/pubmed/36765774 http://dx.doi.org/10.3390/cancers15030816 |
Ejemplares similares
-
Role of high‑sensitivity C‑reactive protein in patients with sarcoma
por: Aggerholm-Pedersen, Ninna, et al.
Publicado: (2023) -
Targeted Treatment of Soft-Tissue Sarcoma
por: Riskjell, Anne Iren, et al.
Publicado: (2023) -
Macrophage Biomarkers sCD163 and sSIRPα in Serum Predict Mortality in Sarcoma Patients
por: Aggerholm-Pedersen, Ninna, et al.
Publicado: (2023) -
The Prognostic Value of Serum Biomarkers in Localized Bone Sarcoma()
por: Aggerholm-Pedersen, Ninna, et al.
Publicado: (2016) -
Inflammation scores as prognostic biomarkers in small cell lung cancer: a systematic review and meta-analysis
por: Winther-Larsen, Anne, et al.
Publicado: (2021)